title: FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.
authors.affiliation: Eli Lilly and Company, Indianapolis, Indiana, USA. brownck@lilly.com
authors.forename: Cynthia K
authors.initials: CK
authors.lastname: Brown
authors.forename: Horst Dieter
authors.initials: HD
authors.lastname: Friedel
authors.forename: Amy R
authors.initials: AR
authors.lastname: Barker
authors.forename: Lucinda F
authors.initials: LF
authors.lastname: Buhse
authors.forename: Susanne
authors.initials: S
authors.lastname: Keitel
authors.forename: Todd L
authors.initials: TL
authors.lastname: Cecil
authors.forename: Johannes
authors.initials: J
authors.lastname: Kraemer
authors.forename: J Michael
authors.initials: JM
authors.lastname: Morris
authors.forename: Christos
authors.initials: C
authors.lastname: Reppas
authors.forename: Mary P
authors.initials: MP
authors.lastname: Stickelmeyer
authors.forename: Chikako
authors.initials: C
authors.lastname: Yomota
authors.forename: Vinod P
authors.initials: VP
authors.lastname: Shah
mesh_terms: D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000331:legislation & jurisprudence / Q000379:methods* / Q000592:standards; D003692:Delayed-Action Preparations / Q000737:chemistry / Q000493:pharmacokinetics / Q000592:standards; D004304:Dosage Forms / Q000592:standards; D004358:Drug Therapy / Q000379:methods* / Q000592:standards; D006801:Humans; D004364:Pharmaceutical Preparations / Q000737:chemistry* / Q000378:metabolism / Q000592:standards; D012957:Societies, Pharmaceutical / Q000331:legislation & jurisprudence / Q000592:standards; D012995:Solubility; D014481:United States
chemical_list: D003692:Delayed-Action Preparations; D004304:Dosage Forms; D004364:Pharmaceutical Preparations